BSEBoard Meeting5d ago · 8 Aug 2026, 07:00 pm
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve We hereby inform you that ....
Tejnaksh Healthcare Ltd · 539428
✦ AI SummaryResults
Tejnaksh Healthcare Ltd has scheduled a board meeting on 13/08/2026 to consider and approve un-audited financial results for the quarter ended 30th June 2026, reappoint an independent director, and consider any other matters with the permission of the chair.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And Closure Of Trading
Window
Attachments (1)
📄pdf
Download →
3d0113be-3175-4399-9c6b-669a5f0e6e54.pdf
View document text
08.08.2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai – 400 001
Dear Sir/Madam,
Scrip Code: 539428
Sub: Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations, 2015 and Closure of Trading
Window
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby
inform you that a meeting of the Board of Directors of the Company will be held on Thursday, 13th August, 2026 at
Shop No 1 Building Name:Shivprasad Harihar Singh Compound, Block Sector:Jogeshwari East, Road: Caves Road.
Pratap Nagar -Mumbai, Maharashtra, 400060 to transact the business as given below:
1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th
June 2026.
2. To consider and reappoint Mr. Suhas Vasantrao Thorat (DIN: 09241231) for the second term as an
Independent Director of the Company.
The reappointment shall be made in accordance with the provisions of Section 149, 152 read with Schedule
IV of the Companies Act, 2013 and Regulation 25 of the SEBI (LODR) Regulations, 2015. The reappointment,
if approved by the Board, shall be subject to the approval of shareholders by way of a special resolution at
the ensuing General Meeting, as mandated under Regulation 25(2A) of the LODR Regulations.
3. Any other matter with the permission of the Chair.
Further, in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation, 2015 and in compliance of
the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02ndApril, 2019, intimation for the closure of
trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 25th
June, 2026 till expiry of 48 hours after the declaration of Un-audited financial results of the Company for the quarter
ended 30th June 2026.
This is for your information and record.
Thanking you.
For Tejnaksh Healthcare Limited
Dr. Ashish V. Rawandale
Managing Director
DIN:- 02005733